Long Non-coding RNA NORAD Contributes to the Proliferation, Invasion and EMT Progression of Prostate Cancer Via the MiR-30a-5p/RAB11A/WNT/β-catenin Pathway

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2020 Dec 9

PMID 33292272

Citations 24

Authors

Yunxia Zhang

Yang Li

Affiliations

Soon will be listed here.

Abstract

Background: Prostate cancer (PC) is common male cancer with high mortality worldwide. Emerging evidence demonstrated that long noncoding RNAs (lncRNAs) play critical roles in various type of cancers including PC by serving as competing endogenous RNAs (ceRNAs) to modulate microRNAs (miRNAs). LncRNA activated by DNA damage (NORAD) was found to be upregulated in PC cells, while the detailed function and regulatory mechanism of NORAD in PC progression remains largely unclear.

Methods: Expression of NORAD in PC tissues and cell lines were detected by real-time quantitative PCR (qRT-PCR). NORAD was respectively overexpressed and knocked down by transfection with pcDNA-NORAD and NORAD siRNA into PC-3 and LNCap cells. Cell proliferation, invasion and apoptosis were determined by using CCK-8, Transwell and Flow cytometry assays, respectively. The target correlations between miR-30-5p and NORAD or RAB11A were confirmed by using dual luciferase reporter assay. Moreover, expression levels of RAB11A, the epithelial-mesenchymal transition (EMT) marker proteins and the Wnt pathway related proteins were measured by Western blotting. Tumor xenograft assay was used to study the effect of NORAD on tumor growth in vivo.

Results: NORAD was upregulated in PC tissues and cells. Overexpression of NORAD promoted cell proliferation, invasion, EMT, and inhibited cell apoptosis; while knockdown of NORAD had the opposite effect. NORAD was found to be functioned as a ceRNA to bind and downregulated miR-30a-5p that was downregulated in PC tumor tissues. Rescue experiments revealed that miR-30a-5p could weaken the NORAD-mediated promoting effects on cell proliferation, invasion and EMT. Furthermore, RAB11A that belongs to a member of RAS oncogene family was verified as a target of miR-30a-5p, and reintroduction of RAB11A attenuated the effects of miR-30a-5p overexpression on cell proliferation, invasion, EMT and apoptosis of PC cells. More importantly, silencing RAB11A partially reversed the promoting effects of NORAD overexpression on cell proliferation, invasion and EMT of PC cells via the WNT/β-catenin pathway. Lastly, tumorigenicity assay in vivo demonstrated that NORAD increased tumor volume and weight via miR-30a-5p /RAB11A pathway.

Conclusion: Our results indicated a significant role of NORAD in mechanisms associated with PC progression. NORAD promoted cell proliferation, invasion and EMT via the miR-30a-5p/RAB11A/WNT/β-catenin pathway, thus inducing PC tumor growth.

Citing Articles

Epigenetic regulation of iron metabolism and ferroptosis in Parkinson's disease: Identifying novel epigenetic targets.

Gao X, Ding J, Xie J, Xu H Acta Pharmacol Sin. 2025; .

PMID: 40069488 DOI: 10.1038/s41401-025-01499-6.

The role of long non-coding RNA NORAD in digestive system tumors.

Perez-Navarro Y, Salinas-Vera Y, Lopez-Camarillo C, Figueroa-Angulo E, Alvarez-Sanchez M Noncoding RNA Res. 2024; 10:55-62.

PMID: 39296642 PMC: 11406672. DOI: 10.1016/j.ncrna.2024.09.002.

Research on lncRNA CTBP1-DT as a potential therapeutic target to regulate cell function in colorectal cancer.

Fan R, Xu T, Kuang Y Discov Oncol. 2024; 15(1):225.

PMID: 38864997 PMC: 11169288. DOI: 10.1007/s12672-024-01085-y.

Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.

Liu X, Liu Z, Zeng D, Hu J, Chen X, Gu J Aging (Albany NY). 2024; 16(4):3934-3954.

PMID: 38382106 PMC: 10929822. DOI: 10.18632/aging.205569.

Wnt/β-catenin-driven EMT regulation in human cancers.

Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R Cell Mol Life Sci. 2024; 81(1):79.

PMID: 38334836 PMC: 10857981. DOI: 10.1007/s00018-023-05099-7.

References

Zhang X, Zhou J, Lu X . The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3. J Cell Physiol. 2017; 233(9):6733-6741. DOI: 10.1002/jcp.26371. View

Hua J, Chen S, He H . Landscape of Noncoding RNA in Prostate Cancer. Trends Genet. 2019; 35(11):840-851. DOI: 10.1016/j.tig.2019.08.004. View

Yoon J, Abdelmohsen K, Gorospe M . Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014; 34:9-14. PMC: 4163095. DOI: 10.1016/j.semcdb.2014.05.015. View

He H, Yang H, Liu D, Pei R . LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p. Am J Transl Res. 2019; 11(1):290-299. PMC: 6357332. View

Wang B, Yang Z, Wang H, Cao Z, Zhao Y, Gong C . MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A. Am J Cancer Res. 2015; 5(9):2719-29. PMC: 4633901. View

Kelly E, Horgan C, McCaffrey M . Rab11 proteins in health and disease. Biochem Soc Trans. 2012; 40(6):1360-7. DOI: 10.1042/BST20120157. View

Liu D, Song L, Liang Q, Hao L, Zhang Z, Han C . Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression. J Cell Physiol. 2019; 234(8):12727-12744. DOI: 10.1002/jcp.27893. View

Yu L, Li X, Li H, Chen H, Liu H . Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer. Tumour Biol. 2016; 37(10):13821-13829. DOI: 10.1007/s13277-016-5172-1. View

Zhang H, Guo H . Long non-coding RNA NORAD induces cell proliferation and migration in prostate cancer. J Int Med Res. 2019; 47(8):3898-3904. PMC: 6726771. DOI: 10.1177/0300060519862076. View

10.

Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R . lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 2014; 281(16):3766-75. DOI: 10.1111/febs.12902. View

11.

Li L, Kang L, Zhao W, Feng Y, Liu W, Wang T . miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect. Cancer Lett. 2017; 400:89-98. DOI: 10.1016/j.canlet.2017.04.034. View

12.

Li W, Li G, Fan Z, Liu T . Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A. Oncol Lett. 2017; 14(2):2559-2565. PMC: 5530176. DOI: 10.3892/ol.2017.6426. View

13.

Davidsson S, Andren O, Ohlson A, Carlsson J, Andersson S, Giunchi F . FOXP3 regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer. Prostate. 2017; 78(1):40-47. PMC: 5725695. DOI: 10.1002/pros.23442. View

14.

Sun T, Liu Z, Zhang R, Ma S, Lin T, Li Y . Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis. Onco Targets Ther. 2020; 13:2957-2972. PMC: 7156234. DOI: 10.2147/OTT.S232839. View

15.

Yu Y, Gao F, He Q, Li G, Ding G . lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143. Mol Ther Nucleic Acids. 2020; 19:751-758. PMC: 6962633. DOI: 10.1016/j.omtn.2019.11.021. View

16.

Chen C, Tang J, Xu S, Zhang W, Jiang H . miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1. Biomed Res Int. 2020; 2020:2547902. PMC: 7174912. DOI: 10.1155/2020/2547902. View

17.

Shi X, Zhang W, Nian X, Lu X, Li Y, Liu F . The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA. Int J Cancer. 2019; 146(2):475-486. DOI: 10.1002/ijc.32422. View

18.

Yu S, Peng H, Zhu Q, Wu Y, Wu F, Han C . Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway. Eur Rev Med Pharmacol Sci. 2019; 23(9):3760-3770. DOI: 10.26355/eurrev_201905_17802. View

19.

Zhang Y, Zhang P, Wan X, Su X, Kong Z, Zhai Q . Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer. Biomed Pharmacother. 2016; 83:936-941. DOI: 10.1016/j.biopha.2016.08.013. View

20.

Jin Y, Cui Z, Li X, Jin X, Peng J . Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Oncotarget. 2017; 8(16):26090-26099. PMC: 5432240. DOI: 10.18632/oncotarget.15318. View